Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Absolute risk of cardiovascular disease and lipid management targets.

× No keyword cloud information.

4 in total

1. Continuous decline in mortality from coronary heart disease in Japan despite a continuous and marked rise in total cholesterol: Japanese experience after the Seven Countries Study.

Authors: Akira Sekikawa; Yoshihiro Miyamoto; Katsuyuki Miura; Kunihiro Nishimura; Bradley J Willcox; Kamal H Masaki; Beatriz Rodriguez; Russell P Tracy; Tomonori Okamura; Lewis H Kuller
Journal: Int J Epidemiol Date: 2015-07-16 Impact factor: 7.196

2. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors: Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal: J Atheroscler Thromb Date: 2018-08-22 Impact factor: 4.928

3. Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China.

Authors: Huanhuan Zhou; Chenghuan Zhang; Jingyu Ni; Xiaoyun Han
Journal: BMC Endocr Disord Date: 2019-10-11 Impact factor: 2.763

4. Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects .

Authors: Koutaro Yokote; Akiyuki Suzuki; Yinhua Li; Nobushige Matsuoka; Tamio Teramoto
Journal: Int J Clin Pharmacol Ther Date: 2019-12 Impact factor: 1.366

4 in total

Absolute risk of cardiovascular disease and lipid management targets.

1. Continuous decline in mortality from coronary heart disease in Japan despite a continuous and marked rise in total cholesterol: Japanese experience after the Seven Countries Study.

2. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

3. Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China.

4. Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects .

4. Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects .